SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.480
-0.070 (-4.52%)
At close: Mar 28, 2025, 4:00 PM
1.516
+0.036 (2.45%)
Pre-market: Mar 31, 2025, 8:08 AM EDT
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $13.66 million as of March 31, 2025. Its market cap has decreased by -74.43% in one year.
Market Cap
13.66M
Enterprise Value
-12.22M
1-Year Change
-74.43%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $13.66M, a decrease of -89.55%. That is a compound annual growth rate of -42.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 13.66M | -60.99% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |